-
Je něco špatně v tomto záznamu ?
Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients
L. Kalisova, J. Michalec, F. Dechterenko, P. Silhan, M. Hyza, M. Chlebovcova, M. Brenova, O. Bezdicek
Status neindexováno Jazyk angličtina Země Německo
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2022
Nature Open Access
od 2022-12-01
PubMed Central
od 2022
ROAD: Directory of Open Access Scholarly Resources
od 2022
- Publikační typ
- časopisecké články MeSH
Schizophrenia has a profound influence on the real-life functioning of patients. There are several factors inherent to the disease course affecting the level of psychosocial functioning. Our study focused on the impact of cognitive deficit and severity of negative symptoms (i.e., the experiential domain (avolition, asociality, and anhedonia) and the expressive domain (blunted affect and alogia)) to explore psychosocial functioning in schizophrenia. Schizophrenia patients (n = 211) were tested for the presence of cognitive impairment using the NIMH-MATRICS: Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Cattery (MCCB; MATRICS Consensus Cognitive Battery) and the extent of negative symptoms using the PANSS (PANSS; Positive and Negative Syndrome Scale-selected items). The level of psychosocial functioning was measured with the Personal and Social Performance Scale (PSP). The path analysis using three regression models was used to analyse variables influencing psychosocial functioning (PSP). One of these models analyzed influence of cognitive functioning (MCCB) and negative schizophrenia symptoms (PANSS selected items reflecting expressive and experiential deficits) as predictors and NART/CRT and disease length as confounders. R2 was 0.54. The direct effect of the MCCB (β = 0.09) on the PSP was suppressed by the strong effect of the negative symptoms (β = -0.64). The presence of cognitive deficits and negative symptoms in our sample of schizophrenia patients significantly influences the level of their psychosocial functioning, a key factor in remission and recovery.
Department of Psychiatry Faculty Hospital Ostrava Czech Republic
Department of Psychology Faculty of Arts Charles University Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23015709
- 003
- CZ-PrNML
- 005
- 20231020093654.0
- 007
- ta
- 008
- 231010s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41537-023-00374-9 $2 doi
- 035 __
- $a (PubMed)37460587
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Kalisova, L $u Department of Psychiatry, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czech Republic
- 245 10
- $a Impact of cognitive performance and negative symptoms on psychosocial functioning in Czech schizophrenia patients / $c L. Kalisova, J. Michalec, F. Dechterenko, P. Silhan, M. Hyza, M. Chlebovcova, M. Brenova, O. Bezdicek
- 520 9_
- $a Schizophrenia has a profound influence on the real-life functioning of patients. There are several factors inherent to the disease course affecting the level of psychosocial functioning. Our study focused on the impact of cognitive deficit and severity of negative symptoms (i.e., the experiential domain (avolition, asociality, and anhedonia) and the expressive domain (blunted affect and alogia)) to explore psychosocial functioning in schizophrenia. Schizophrenia patients (n = 211) were tested for the presence of cognitive impairment using the NIMH-MATRICS: Measurement and Treatment Research to Improve Cognition in Schizophrenia Consensus Cognitive Cattery (MCCB; MATRICS Consensus Cognitive Battery) and the extent of negative symptoms using the PANSS (PANSS; Positive and Negative Syndrome Scale-selected items). The level of psychosocial functioning was measured with the Personal and Social Performance Scale (PSP). The path analysis using three regression models was used to analyse variables influencing psychosocial functioning (PSP). One of these models analyzed influence of cognitive functioning (MCCB) and negative schizophrenia symptoms (PANSS selected items reflecting expressive and experiential deficits) as predictors and NART/CRT and disease length as confounders. R2 was 0.54. The direct effect of the MCCB (β = 0.09) on the PSP was suppressed by the strong effect of the negative symptoms (β = -0.64). The presence of cognitive deficits and negative symptoms in our sample of schizophrenia patients significantly influences the level of their psychosocial functioning, a key factor in remission and recovery.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Michalec, J $u Department of Psychiatry, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czech Republic. michalec.jirka@gmail.com
- 700 1_
- $a Dechterenko, F $u Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic
- 700 1_
- $a Silhan, P $u Department of Psychiatry, Faculty Hospital, Ostrava, Czech Republic $1 https://orcid.org/0000000231459215
- 700 1_
- $a Hyza, M $u Department of Psychiatry, Faculty Hospital, Ostrava, Czech Republic
- 700 1_
- $a Chlebovcova, M $u Department of Psychiatry, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czech Republic
- 700 1_
- $a Brenova, M $u Department of Psychiatry, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czech Republic
- 700 1_
- $a Bezdicek, O $u Department of Psychology, Faculty of Arts, Charles University, Prague, Czech Republic $u Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine and General University Hospital in Prague, Charles University, Prague, Czech Republic $1 https://orcid.org/0000000251080181 $7 xx0106259
- 773 0_
- $w MED00213976 $t Schizophrenia (Heidelberg, Germany) $x 2754-6993 $g Roč. 9, č. 1 (2023), s. 43
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37460587 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231010 $b ABA008
- 991 __
- $a 20231020093648 $b ABA008
- 999 __
- $a ok $b bmc $g 1997234 $s 1202071
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2023 $b 9 $c 1 $d 43 $e 20230717 $i 2754-6993 $m Schizophrenia $n Schizophrenia (Heidelb) $x MED00213976
- LZP __
- $a Pubmed-20231010